diff --git a/_posts/2023-11-07-GLP1_SGLT2.md b/_posts/2023-11-07-GLP1_SGLT2.md
index 231dfc8..9333ff8 100644
--- a/_posts/2023-11-07-GLP1_SGLT2.md
+++ b/_posts/2023-11-07-GLP1_SGLT2.md
@@ -65,4 +65,4 @@ The American Society of Anesthesiologists (ASA) Task Force on Preoperative Fasti
 - If the patient has no GI symptoms, but the GLP-1 agonists were not held as advised, proceed with ‘full stomach’ precautions or consider evaluating gastric volume by ultrasound, if possible and if proficient with the technique. If the stomach is empty, proceed as usual. If the stomach is full or if gastric ultrasound inconclusive or not possible, consider delaying the procedure or treat the patient as ‘full stomach’ and manage accordingly. Discuss the concerns of potential risk of regurgitation and pulmonary aspiration of gastric contents with the proceduralist/surgeon and the patient.
 - There is no evidence to suggest the optimal duration of fasting for patients on GLP-1 agonists. Therefore, until we have adequate evidence, we suggest following the current ASA fasting guidelines.
 
-Refer to the [Gastric Ultrasound Blog Post](dzauski585.github.io/posts/gastric_US/)
\ No newline at end of file
+Refer to the [Gastric Ultrasound Blog Post](https://dzauski585.github.io/posts/gastric_US/)
\ No newline at end of file